Meridian Investment Counsel Inc. Buys 15,188 Shares of iShares U.S. Medical Devices ETF (NYSEARCA:IHI)

Meridian Investment Counsel Inc. increased its stake in iShares U.S. Medical Devices ETF (NYSEARCA:IHIFree Report) by 357.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,438 shares of the company’s stock after buying an additional 15,188 shares during the period. Meridian Investment Counsel Inc.’s holdings in iShares U.S. Medical Devices ETF were worth $1,134,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of IHI. Blue Trust Inc. lifted its stake in shares of iShares U.S. Medical Devices ETF by 86.5% in the 4th quarter. Blue Trust Inc. now owns 1,981 shares of the company’s stock valued at $116,000 after purchasing an additional 919 shares during the period. JPMorgan Chase & Co. lifted its position in iShares U.S. Medical Devices ETF by 127.6% during the third quarter. JPMorgan Chase & Co. now owns 1,202,394 shares of the company’s stock valued at $71,206,000 after buying an additional 674,168 shares during the period. Savant Capital LLC bought a new stake in shares of iShares U.S. Medical Devices ETF during the 4th quarter valued at $345,000. FMR LLC grew its position in shares of iShares U.S. Medical Devices ETF by 6.1% in the 3rd quarter. FMR LLC now owns 28,988 shares of the company’s stock worth $1,717,000 after buying an additional 1,660 shares during the period. Finally, Salem Investment Counselors Inc. increased its stake in shares of iShares U.S. Medical Devices ETF by 41.5% in the 4th quarter. Salem Investment Counselors Inc. now owns 4,686 shares of the company’s stock worth $273,000 after acquiring an additional 1,375 shares in the last quarter.

iShares U.S. Medical Devices ETF Stock Performance

IHI stock opened at $59.42 on Monday. The firm has a 50 day moving average price of $62.65 and a 200-day moving average price of $60.60. iShares U.S. Medical Devices ETF has a 52-week low of $53.72 and a 52-week high of $65.18. The firm has a market capitalization of $4.67 billion, a price-to-earnings ratio of 29.98 and a beta of 0.90.

iShares U.S. Medical Devices ETF Company Profile

(Free Report)

The iShares U.S. Medical Devices ETF (IHI) is an exchange-traded fund that is based on the DJ US Select \u002F Medical Equipment index, a market-cap-weighted index of manufacturers and distributors of medical devices in the US. IHI was launched on May 1, 2006 and is managed by BlackRock.

Featured Articles

Want to see what other hedge funds are holding IHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S. Medical Devices ETF (NYSEARCA:IHIFree Report).

Institutional Ownership by Quarter for iShares U.S. Medical Devices ETF (NYSEARCA:IHI)

Receive News & Ratings for iShares U.S. Medical Devices ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Medical Devices ETF and related companies with MarketBeat.com's FREE daily email newsletter.